Investors considering a purchase of Harrow Inc (Symbol: HROW) stock, but tentative about paying the going market price of $35.48/share, might benefit from considering selling puts among the ...

Investors considering a purchase of Harrow Inc (Symbol: HROW) shares, but tentative about paying the going market price of $32.54/share, might benefit from considering selling puts among the ...

Harrow HROW will release its quarterly earnings report on Monday, 2025-08-11. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Harrow to report an earnings per ...

Harrow, Inc. shares have dropped 45% since spring 2023, but the launch of Iheezo and Vevye suggest a potential rebound. Iheezo, an ocular anesthetic, has a substantial market opportunity and is ...

Harrow is a company focused on eye health with a strong distribution platform and CEO ownership. Q3 earnings were below expectations, and guidance was lowered, raising concerns about operational ...